Voloridge Investment Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.6M Buy
54,446
+5,961
+12% +$1.71M 0.06% 394
2025
Q1
$14.9M Buy
48,485
+41,621
+606% +$12.8M 0.06% 437
2024
Q4
$2.42M Buy
6,864
+2,221
+48% +$784K 0.01% 920
2024
Q3
$1.66M Buy
+4,643
New +$1.66M 0.01% 962
2024
Q2
Sell
-13,263
Closed -$3.05M 1373
2024
Q1
$3.05M Buy
+13,263
New +$3.05M 0.01% 759
2023
Q4
Sell
-2,133
Closed -$482K 1501
2023
Q3
$482K Buy
+2,133
New +$482K ﹤0.01% 1216
2023
Q2
Sell
-4,478
Closed -$1M 1585
2023
Q1
$1M Buy
+4,478
New +$1M 0.01% 1126
2021
Q4
Sell
-24,953
Closed -$4.61M 1862
2021
Q3
$4.61M Buy
24,953
+17,268
+225% +$3.19M 0.03% 718
2021
Q2
$1.38M Buy
+7,685
New +$1.38M 0.01% 1140
2020
Q4
Sell
-71,596
Closed -$7.23M 1585
2020
Q3
$7.23M Buy
71,596
+30,106
+73% +$3.04M 0.06% 336
2020
Q2
$5.02M Buy
+41,490
New +$5.02M 0.06% 354
2020
Q1
Sell
-8,700
Closed -$766K 1422
2019
Q4
$766K Sell
8,700
-6,550
-43% -$577K 0.01% 718
2019
Q3
$1.22M Sell
15,250
-20,184
-57% -$1.61M 0.02% 586
2019
Q2
$2.77M Buy
+35,434
New +$2.77M 0.08% 264
2017
Q2
Sell
-6,426
Closed -$870K 586
2017
Q1
$870K Buy
+6,426
New +$870K 0.02% 399
2016
Q2
Sell
-3,904
Closed -$435K 404
2016
Q1
$435K Buy
+3,904
New +$435K 0.01% 278
2015
Q4
Sell
-25,909
Closed -$3.4M 311
2015
Q3
$3.4M Buy
25,909
+22,009
+564% +$2.89M 0.16% 137
2015
Q2
$678K Sell
3,900
-9,041
-70% -$1.57M 0.03% 244
2015
Q1
$2.23M Buy
+12,941
New +$2.23M 0.11% 176
2014
Q4
Sell
-6,300
Closed -$810K 232
2014
Q3
$810K Buy
+6,300
New +$810K 0.04% 88
2014
Q1
Sell
-3,109
Closed -$352K 131
2013
Q4
$352K Buy
+3,109
New +$352K 0.07% 89